Article
Constructing Immune Related Prognosis Score Based on Signatures to Predict the Benefit of Immunotherapy in Colorectal Cancer
2022-07-06
Abstract excerpt
Since FDA approved immune checkpoint inhibitors for the treatment of colorectal cancer in 2017, there have been significant differences in the response of colorectal cancer patients to immune checkpoint inhibitors. In order to achieve better clinical benefits in patients with colorectal cancer in immunotherapy, we urgently need to find a biomarker to evaluate whether colorectal cancer patients respond to immunothe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 06e31c8c-970a-5a68-ad74-51a9efcc97da
- DOI
- 10.21203/rs.3.rs-1557469/v2
